International Assets Investment Management LLC Takes $2.35 Million Position in Cardinal Health, Inc. $CAH

International Assets Investment Management LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 11,450 shares of the company’s stock, valued at approximately $2,353,000.

A number of other hedge funds have also added to or reduced their stakes in CAH. Wellington Management Group LLP raised its position in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Holocene Advisors LP boosted its holdings in shares of Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after purchasing an additional 1,128,358 shares in the last quarter. Barclays PLC increased its stake in shares of Cardinal Health by 109.3% in the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after purchasing an additional 827,446 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock valued at $149,504,000 after purchasing an additional 708,995 shares during the last quarter. Finally, Victory Capital Management Inc. raised its holdings in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Down 0.7%

NYSE CAH opened at $183.97 on Friday. The company has a market cap of $43.09 billion, a price-to-earnings ratio of 28.13, a price-to-earnings-growth ratio of 1.10 and a beta of 0.53. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The business’s fifty day moving average is $211.71 and its 200 day moving average is $206.94.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s payout ratio is currently 31.19%.

Wall Street Analysts Forecast Growth

CAH has been the topic of several research analyst reports. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. TD Cowen boosted their target price on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Weiss Ratings raised shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday. Mizuho raised their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research note on Friday, February 6th. Finally, Leerink Partners reaffirmed an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.